These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

454 related articles for article (PubMed ID: 17278788)

  • 41. [How do you want to die? The therapeutic options in ventricular tachyarrhythmia at the end of the anti-arrhythmia drug era].
    Seipel L
    Z Kardiol; 1995 Oct; 84(10):787-90. PubMed ID: 7502564
    [No Abstract]   [Full Text] [Related]  

  • 42. Long-Term Clinical Outcome of Arrhythmogenic Right Ventricular Cardiomyopathy in Individuals With a p.S358L Mutation in TMEM43 Following Implantable Cardioverter Defibrillator Therapy.
    Hodgkinson KA; Howes AJ; Boland P; Shen XS; Stuckless S; Young TL; Curtis F; Collier A; Parfrey PS; Connors SP
    Circ Arrhythm Electrophysiol; 2016 Mar; 9(3):. PubMed ID: 26966288
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Pursuing the "Holy Grail".
    Dickfeld T
    Circ Cardiovasc Imaging; 2012 Mar; 5(2):167-70. PubMed ID: 22438421
    [No Abstract]   [Full Text] [Related]  

  • 44. Abdominal submuscular implant of subcutaneous implantable cardioverter-defibrillator in a young child.
    Kwok SY; Yam N; Lun KS; Chen RH; Au TW; Yung TC
    Europace; 2018 Sep; 20(FI2):f248. PubMed ID: 29401320
    [No Abstract]   [Full Text] [Related]  

  • 45. Noninvasive imaging markers associated with sudden cardiac death.
    van der Bijl P; Delgado V; Bax JJ
    Trends Cardiovasc Med; 2016 May; 26(4):348-60. PubMed ID: 26632012
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Implantable defibrillators and antiarrhythmic drugs in patients at risk for lethal arrhythmias.
    Zivin A; Bardy GH
    Am J Cardiol; 1999 Nov; 84(9A):63R-68R. PubMed ID: 10568662
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Implantable cardioverter-defibrillator therapy for prevention of sudden cardiac death.
    Akhtar M; Jazayeri MR; Sra JS; Dhala A; Deshpande S; Blanck Z; Axtell K
    Cardiol Clin; 1993 Feb; 11(1):97-108. PubMed ID: 8435827
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Sudden cardiac death].
    Stoupel E; Jottrand M
    Rev Med Brux; 2001 Dec; 22(6):488-96. PubMed ID: 11811044
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Automatic defibrillator or anti-arrhythmia drugs for the therapy of patients who survived heart arrest or with syncopal ventricular arrhythmias? A critical analysis of the models relative to the studies in progress].
    Cappato R; Kuck KH
    G Ital Cardiol; 1994 Dec; 24(12):1613-21. PubMed ID: 7883135
    [No Abstract]   [Full Text] [Related]  

  • 50. The appropriate evaluation of the patient at risk for sudden death from ventricular arrhythmias.
    Green MS; Ricci J; Wolfe K
    Can J Cardiol; 2000 Jun; 16 Suppl C():13C-5C. PubMed ID: 10887271
    [No Abstract]   [Full Text] [Related]  

  • 51. Matching cardiac rhythm management technology to patient needs: pacing/ablation/implantable cardioverter defibrillators.
    Cannom DS
    Am J Cardiol; 2000 Nov; 86(9A):58K-70K. PubMed ID: 11084102
    [TBL] [Abstract][Full Text] [Related]  

  • 52. HRS/ACC/AHA expert consensus statement on the use of implantable cardioverter-defibrillator therapy in patients who are not included or not well represented in clinical trials.
    Kusumoto FM; Calkins H; Boehmer J; Buxton AE; Chung MK; Gold MR; Hohnloser SH; Indik J; Lee R; Mehra MR; Menon V; Page RL; Shen WK; Slotwiner DJ; Stevenson LW; Varosy PD; Welikovitch L
    Circulation; 2014 Jul; 130(1):94-125. PubMed ID: 24815500
    [No Abstract]   [Full Text] [Related]  

  • 53. Cardiac Sympathetic Innervation and Appropriate Therapies in Patients With an Implantable Cardioverter-defibrillator in Primary Prevention.
    Navarro-Peñalver M; Mohamed-Salem L; Domínguez F; de Haro-Del Moral FJ; Fernández-Lozano I; Pascual-Figal DA
    Rev Esp Cardiol (Engl Ed); 2019 Feb; 72(2):180-182. PubMed ID: 29650449
    [No Abstract]   [Full Text] [Related]  

  • 54. [Primary prevention of sudden cardiac death].
    Reek S; Geller JC; Klein HU
    Dtsch Med Wochenschr; 2001 Apr; 126(15):435-8. PubMed ID: 11347006
    [No Abstract]   [Full Text] [Related]  

  • 55. [Prevention of sudden death and the countermeasures--implantable defibrillators].
    Kasanuki H
    Nihon Naika Gakkai Zasshi; 1998 Jan; 87(1):105-16. PubMed ID: 9513555
    [No Abstract]   [Full Text] [Related]  

  • 56. [Indications for implantable cardioverter-defibrillator].
    Tebbenjohanns J; Niehaus M; Korte T
    Dtsch Med Wochenschr; 2002 Oct; 127(41):2120-4. PubMed ID: 12397558
    [No Abstract]   [Full Text] [Related]  

  • 57. Arrhythmias in hypertrophic cardiomyopathy.
    Kuck KH
    Pacing Clin Electrophysiol; 1997 Oct; 20(10 Pt 2):2706-13. PubMed ID: 9358518
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Sudden cardiac death prevention: antiarrhythmic drugs and the implantable cardioverter-defibrillator.
    Domanski MJ
    J Interv Cardiol; 1995 Feb; 8(1):9-15. PubMed ID: 10155222
    [No Abstract]   [Full Text] [Related]  

  • 59. Role of drugs and devices in patients at risk of sudden cardiac death.
    Boriani G; Diemberger I; Valzania C; Biffi M; Martignani C; Raschi E; Mantovani V; Ziacchi M; Bertini M; De Ponti F; Branzi A
    Fundam Clin Pharmacol; 2010 Oct; 24(5):575-94. PubMed ID: 20608989
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Early repolarization associated with sudden death: insights from noninvasive electrocardiographic imaging.
    Ghosh S; Cooper DH; Vijayakumar R; Zhang J; Pollak S; Haïssaguerre M; Rudy Y
    Heart Rhythm; 2010 Apr; 7(4):534-7. PubMed ID: 20153422
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.